The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals
Open accessAbstract
Acinetobacter baumannii has become a major concern for scientific attention due to extensive antimicrobial resistance. This resistance causes an increase in mortality rate because strains resistant to antimicrobial agents are a major challenge for physicians and healthcare workers regarding the eradication of either hospital or community-based infections. These strains with emerging resistance are a serious issue for patients in the intensive care unit (ICU). Antibiotic resistance has increased because of the acquirement of mobile genetic elements such as transposons, plasmids, and integrons and causes the prevalence of multidrug resistance strains (MDR). In addition, an increase in carbapenem resistance, which is used as last line antibiotic treatment to eliminate infections with multidrug-resistant Gram-negative bacteria, is a major concern. Carbapenems resistant A. baumannii (CR-Ab) is a worldwide problem. Because these strains are often resistant to all other commonly used antibiotics. Therefore, pathogenic multi-drug resistance A. baumannii (MDR-Ab) associated infections become hard to eradicate. Plasmid-mediated resistance causes outbreaks of extensive drug-resistant. A. baumannii (XDR-Ab). In addition, recent outbreaks relating to livestock and community settings illustrate the existence of large MDR-Ab strain reservoirs within and outside hospital settings. The purpose of this review, proper monitoring, prevention, and treatment are required to control (XDR-Ab) infections. Attachment, the formation of biofilms and the secretion of toxins, and low activation of inflammatory responses are mechanisms used by pathogenic A. baumannii strain. This review will discuss some aspects associated with antibiotics resistance in A. baumannii as well as cover briefly phage therapy as an alternative therapeutic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Structural identification of a bacterial quorum-sensing signal containing boron
Chen, X., Schauder, S., Potier, N., Van Dorsselaer, A., Pelczer, I., Bassler, B. L., & Hughson, F. M. (2002) · Nature · doi:10.1038/415545a · Cited by 1,571
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Lee, J., & Zhang, L. (2015) · Protein & Cell · doi:10.1007/s13238-014-0100-x · Cited by 1,346
Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011) · Bacteriophage · doi:10.4161/bact.1.1.14942 · Cited by 1,149
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Viral and Bacterial Interactions in the Upper Respiratory Tract
Bosch, A. A. T. M., Biesbroek, G., Trzcinski, K., Sanders, E. A. M., & Bogaert, D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003057 · Cited by 651
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp
Coyne, S., Courvalin, P., & Périchon, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-10 · Cited by 505
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Gordillo Altamirano, F., Forsyth, J. H., Patwa, R., Kostoulias, X., Trim, M., Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00830-7 · Cited by 349
Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces
Espinal, P., Martí, S., & Vila, J. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.08.013 · Cited by 328
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Russo, T. A., Luke, N. R., Beanan, J. M., Olson, R., Sauberan, S. L., MacDonald, U., Schultz, L. W., Umland, T. C., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00366-10 · Cited by 324
Adhesins Involved in Attachment to Abiotic Surfaces by Gram-Negative Bacteria
Berne, C., Ducret, A., Hardy, G. G., & Brun, Y. V. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0018-2015 · Cited by 323
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Cisneros, J. M., & Rodríguez-Baño, J. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00487.x · Cited by 322
Regulation of Acinetobacter Baumannii Biofilm Formation
Gaddy, J. A., & Actis, L. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.5 · Cited by 321
Flavier, A. B., Clough, S. J., Schell, M. A., & Denny, T. P. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.5661945.x · Cited by 311
Revisiting phage therapy: new applications for old resources
Nobrega, F. L., Costa, A. R., Kluskens, L. D., & Azeredo, J. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.006 · Cited by 310
β-Lactams: chemical structure, mode of action and mechanisms of resistance
Fernandes, R., Amador, P., & Prudêncio, C. (2012) · Reviews in Medical Microbiology · doi:10.1097/mrm.0b013e3283587727 · Cited by 307
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review
Hussein, N. H., AL-Kadmy, I. M. S., Taha, B. M., & Hussein, J. D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06307-y · Cited by 290
Self-citationHammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Isolation and Characterization of an Autoinducer Synthase from Acinetobacter baumannii
Niu, C., Clemmer, K. M., Bonomo, R. A., & Rather, P. N. (2008) · Journal of Bacteriology · doi:10.1128/jb.01929-07 · Cited by 279
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
Structural Basis of Acyl-homoserine Lactone-Dependent Signaling
Churchill, M. E. A., & Chen, L. (2011) · Chemical Reviews · doi:10.1021/cr1000817 · Cited by 271
Brossard, K. A., & Campagnari, A. A. (2012) · Infection and Immunity · doi:10.1128/iai.05913-11 · Cited by 266
High burden of antimicrobial resistance in Asia
Jean, S.-S., & Hsueh, P.-R. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.009 · Cited by 249
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy064 · Cited by 239
Donald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
The DSF Family of Cell–Cell Signals: An Expanding Class of Bacterial Virulence Regulators
Ryan, R. P., An, S.-Q., Allan, J. H., McCarthy, Y., & Dow, J. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004986 · Cited by 225
Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii
Smani, Y., Fàbrega, A., Roca, I., Sánchez-Encinales, V., Vilà, J., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-13 · Cited by 212
Hetta, H. F., Al-Kadmy, I. M. S., Khazaal, S. S., Abbas, S., Suhail, A. M., El‐Mokhtar, M. A., Ellah, N. H. A., Ahmed, E. A., Abd-ellatief, R. B., El-Masry, E. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90208-4 · Cited by 181
Self-citationDifferential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Knapp, S., Wieland, C. W., Florquin, S., Pantophlet, R., Dijkshoorn, L., Tshimbalanga, N., Akira, S., & van der Poll, T. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-730oc · Cited by 180
Sheldon, J. R., & Skaar, E. P. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008995 · Cited by 177
Jeon, J., Park, J., & Yong, D. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1443-5 · Cited by 164
Giannouli, M., Antunes, L. C. S., Marchetti, V., Triassi, M., Visca, P., & Zarrilli, R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-282 · Cited by 160
Quorum sensing in Acinetobacter: an emerging pathogen
Bhargava, N., Sharma, P., & Capalash, N. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.512269 · Cited by 158
Lee, H.-Y., Chen, C., Wu, S.-R., Huang, C.-W., & Chiu, C. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000125 · Cited by 151
Héritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii
Eijkelkamp, B. A., Stroeher, U. H., Hassan, K. A., Paulsen, I. T., & Brown, M. H. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1020 · Cited by 123
Chow, J. Y., Yang, Y., Tay, S. B., Chua, K. L., & Yew, W. S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02410-13 · Cited by 114
Erridge, C., Moncayo-Nieto, O. L., Morgan, R., Young, M., & Poxton, I. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46823-0 · Cited by 112
Fu, Y., Zhou, J., Zhou, H., Yang, Q., Wei, Z., Yu, Y., & Li, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq027 · Cited by 112
Polymyxins for CNS infections: Pharmacology and neurotoxicity
Velkov, T., Dai, C., Ciccotosto, G. D., Cappai, R., Hoyer, D., & Li, J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.012 · Cited by 111
Evans, B. A., Hamouda, A., Towner, K. J., & Amyes, S. G. B. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01919.x · Cited by 98
Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals
Villegas, M. V., Kattán, J. N., Correa, A., Lolans, K., Guzmán, A. M., Woodford, N., Livermore, D. M., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-07 · Cited by 93
Chopra, T., Marchaim, D., Awali, R. A., Krishna, A., Johnson, P., Tansek, R., Chaudary, K., Lephart, P., Slim, J., Hothi, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-13 · Cited by 91
Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii
Yin, S., Huang, G., Zhang, Y., Jiang, B., Yang, Z., Dong, Z.-W., You, B. R., Yuan, Z., Hu, F., Zhao, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486117 · Cited by 86
Shen, G., Wang, J., Wen, F.-S., Chang, K., Kuo, C.-F., Lin, C.-H., Luo, H.-R., & Hung, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046537 · Cited by 82
Brown, S., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01096.x · Cited by 78
Moffatt, J. H., Harper, M., Mansell, A. S., Crane, B., Fitzsimons, T. C., Nation, R. L., Li, J., Adler, B., & Boyce, J. D. (2012) · Infection and Immunity · doi:10.1128/iai.01362-12 · Cited by 78
Goel, V., & Kapil, A. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-16 · Cited by 75
Musić, M. Š., Hrenović, J., Goić-Barišić, I., Hunjak, B., Škorić, D., & Ivanković, T. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.04.005 · Cited by 73
Cai, Z., Yuan, Z., Zhang, H., Pan, Y., Wu, Y., Xiu-Qi, T., Wang, F., Wang, L., & Qian, W. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006304 · Cited by 71
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America
Rodríguez, C. H., Yarhui, N. B., Nastro, M., Quezada, T. N., Cañarte, G. C., Ventura, R. M., Cuba, T. U., Valenzuela, N., Roach, F., Mota, M. I., et al. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000328 · Cited by 69
Leal, N. C., Campos, T. D. L., Rezende, A. M., Docena, C., Mendes-Marques, C. L., Cavalcanti, F. L. D. S., Wallau, G. L., Rocha, I. V., Cavalcanti, C. D. L. B., Veras, D. L., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01176 · Cited by 56
Application of phage therapy during bivalve depuration improves Escherichia coli decontamination
Pereira, C., Moreirinha, C., Teles, L., Rocha, R. J. M., Calado, R., Romalde, J. L., Nunes, M. L., & Almeida, A. (2016) · Food Microbiology · doi:10.1016/j.fm.2016.09.003 · Cited by 55
Hakemi-Vala, M., Hallajzadeh, M., Hashemi, A., Goudarzi, H., Tarhani, M., Tabrizi, M., & Bazmi, F. (2014) · Europe PMC (PubMed Central) · Cited by 54
Asaad, A. M., Ansari, S., Ajlan, S., & Awad, S. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s261939 · Cited by 54
Lanjri, S., Uwingabiye, J., Frikh, M., Abdellatifi, L., Kasouati, J., Maleb, A., Bait, A., Lemnouer, A., & Elouennass, M. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0195-y · Cited by 40
Hujer, A. M., Higgins, P. G., Rudin, S. D., Buser, G. L., Marshall, S. H., Xanthopoulou, K., Seifert, H., Rojas, L. J., Domitrovic, T., Cassidy, P. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00797-17 · Cited by 38
Chen, Y., Yang, Y., Liu, L., Qiu, G.-B., Han, X., Tian, S., Zhao, J., Chen, F., Grundmann, H., Li, H., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3359-3 · Cited by 37
Karmostaji, A., Peerayeh, S. N., & Salmanian, A. H. (2013) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.8219 · Cited by 32
OXA-134, a Naturally Occurring Carbapenem-Hydrolyzing Class D β-Lactamase from Acinetobacter lwoffii
Figueiredo, S., Poirel, L., Seifert, H., Mugnier, P. D., Benhamou, D., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-10 · Cited by 29
Singkham-in, U., & Chatsuwan, T. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000845 · Cited by 17
Dehbalaei, M. A., Peerayeh, S. N., Taherikalani, M., & Behmanesh, M. (2017) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.13790 · Cited by 15
Shin, S. Y., Koh, D., Lim, Y., & Lee, Y. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06091-1 · Cited by 8
Marjani, M. F. A., Ali, F. S., Authman, S. H., Al-Kadmy, I. M. S., & Amir, R. M. A. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100782 · Cited by 7
Self-citation
Cited by
Jackson-Litteken, C. D., Di Venanzio, G., Le, N.-H., Scott, N. E., Djahanschiri, B., Distel, J. S., Pardue, E. J., Ebersberger, I., & Feldman, M. F. (2022) · mBio · doi:10.1128/mbio.00258-22 · Cited by 38
Metadata
- Authors
- Ibrahim, S., Al-Saryi, N., Al-Kadmy, I. M. S., & Aziz, S. N.
- Venue
- Molecular Biology Reports
- Published
- 2021-08-30
- Volume
- 48
- Issue
- 10
- Pages
- 6987-6998
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W3197421632
- Cited by
- 388
- References
- 85
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.